About: Natalie J Thornburg

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Natalie J Thornburg Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	ikertzailea (eu) researcher (en) 연구원 (ko) 研究者 (ja) araştırmacı (tr) дослідниця (uk) эрдэмтэн (mn) वैज्ञानिक (hi) изилдөөчү (ky) հետազոտող (hy) onderzoeker (nl) hulumtuese (sq)
rdfs:label	Natalie J Thornburg (en) Natalie J Thornburg (es) Natalie J Thornburg (nl) Natalie J Thornburg (ast)
skos:prefLabel	Natalie J Thornburg (en) Natalie J Thornburg (es) Natalie J Thornburg (nl) Natalie J Thornburg (ast)
name	Natalie J Thornburg (en) Natalie J Thornburg (es) Natalie J Thornburg (nl) Natalie J Thornburg (ast)
Scopus author ID	wds:Q63881076-9EB78D3E-039A-4397-B5E9-3381615AE68D
Scopus author ID	6602664202
given name	wds:Q63881076-F943DD20-50CA-4902-BD22-760C1F5CE0C2
given name	Natalie
instance of	wds:Q63881076-429C2132-7246-4FBF-876F-9D9E11B25679
instance of	Homo sapiens
skos:altLabel	Natalie Thornburg (en)
occupation	wds:Q63881076-F710D122-2A3A-41A3-9FF2-5CF04629234C
sex or gender	wds:Q63881076-5B914CAA-E700-4CB0-AFD2-F5B98049B31F
on focus list of Wikimedia project	wds:Q63881076-2F389F8A-D284-48FD-A99E-43893AC4253A
family name	wds:Q63881076-D34B5179-6C25-4B8F-910D-CCF8F2AD5370
occupation	researcher
sex or gender	female organism
on focus list of Wikimedia project	WikiProject COVID-19
family name	Thornburg
ORCID iD	wds:Q63881076-6F48F040-8D3E-46CD-B5C5-999E00AD7965
ORCID iD	https://orcid.org/0000-0003-3523-3616
ORCID iD	0000-0003-3523-3616
ORKG ID	wds:Q63881076-1da15389-0b34-4f9b-b299-138470baa435
ORKG ID	R75501
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q63881076
is author of	Respiratory syncytial virus regulates human microRNAs by using mechanisms involving beta interferon and NF-κB. Comparison of multiple vaccine vectors in a single heterologous prime-boost trial Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial. H7N9 influenza virus neutralizing antibodies that possess few somatic mutations Human antibodies that neutralize respiratory droplet transmissible H5N1 influenza viruses Transforming growth factor beta is a major regulator of human neonatal immune responses following respiratory syncytial virus infection Vaccine-elicited antibody that neutralizes H5N1 influenza and variants binds the receptor site and polymorphic sites A chemically programmed antibody is a long-lasting and potent inhibitor of influenza neuraminidase Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes. Gold nanorod vaccine for respiratory syncytial virus Advances in Emerging and Neglected Infectious Diseases 2018 Inclusion of MERS-spike protein ELISA in algorithm to determine serologic evidence of MERS-CoV infection Infectious MERS-CoV Isolated From a Mildly Ill Patient, Saudi Arabia Middle East Respiratory Syndrome Coronavirus Infection Dynamics and Antibody Responses among Clinically Diverse Patients, Saudi Arabia Influenza and respiratory syncytial virus in infants study (IRIS) of hospitalized and non-ill infants aged <1 year in four countries: study design and methods Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States First 12 patients with coronavirus disease 2019 (COVID-19) in the United States Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 Antibody Responses after Classroom Exposure to Teacher with Coronavirus Disease, March 2020 Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old Scope and extent of healthcare-associated Middle East respiratory syndrome coronavirus transmission during two contemporaneous outbreaks in Riyadh, Saudi Arabia, 2017 Development and Evaluation of a Multiplexed Immunoassay for Simultaneous Detection of Serum IgG Antibodies to Six Human Coronaviruses Risk Factors for MERS-CoV Seropositivity among Animal Market and Slaughterhouse Workers, Abu Dhabi, United Arab Emirates, 2014-2017 Serologic Follow-up of Middle East Respiratory Syndrome Coronavirus Cases and Contacts-Abu Dhabi, United Arab Emirates Lack of Serologic Evidence of Infection Among Health Care Personnel and Other Contacts of First 2 Confirmed Patients With COVID-19 in Illinois, 2020 An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility Comparison of Estimated SARS-CoV-2 Seroprevalence through Commercial Laboratory Residual Sera Testing and a Community Survey US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020 Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020 Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020 Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model. Vaccination with Venezuelan equine encephalitis replicons encoding cowpox virus structural proteins protects mice from intranasal cowpox virus challenge Identification of Epstein-Barr virus RK-BARF0-interacting proteins and characterization of expression pattern. Recognition of influenza H3N2 variant virus by human neutralizing antibodies Household Transmission of SARS-CoV-2 in the United States Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for COVID-19 Patients - Nashville, Tennessee Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses - Wisconsin, September-October 2020 SARS-CoV-2 Infections and Serologic Responses from a Sample of U.S. Navy Service Members - USS Theodore Roosevelt, April 2020 A prospective cohort study in non-hospitalized household contacts with SARS-CoV-2 infection: symptom profiles and symptom change over time Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network - 12 States, April-August 2020 An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 and multiple endemic, epidemic and bat coronavirus 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales 2328. Human Respiratory Syncytial Virus Subgroups among Hospitalized Infants in the United States, 2015–2016 Duplex real-time RT-PCR assay for detection and subgroup-specific identification of human respiratory syncytial virus Lack of antibodies to SARS-CoV-2 in a large cohort of previously infected persons Multihospital Outbreak of a Middle East Respiratory Syndrome Coronavirus Deletion Variant, Jordan: A Molecular, Serologic, and Epidemiologic Investigation Isolation and growth characterization of novel full length and deletion mutant human MERS-CoV strains from clinical specimens collected during 2015

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 182 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software